COAPT-Like MTEER Benefits Persisted in Real-World Populations Tags Mitral Annular Calcification Mitral Regurgitation Mitral Stenosis Mitral Valve Prolapse Percutaneous Coronary Intervention Read more about COAPT-Like MTEER Benefits Persisted in Real-World Populations
Low Subendocardial Flow Reserve Linked to Higher CV Risk on PET Tags CT scan Heart Failure Myocardial Infarction Read more about Low Subendocardial Flow Reserve Linked to Higher CV Risk on PET
ESH 2026: Non-Dipping BP Pattern Predominated After Ischemic Stroke Tags Hypertension Ischemic Stroke Read more about ESH 2026: Non-Dipping BP Pattern Predominated After Ischemic Stroke
ESH 2026: Nocturnal HBPM and ABPM Show Limited Interchangeability in High-Risk Pregnancy Tags Hypertension RPRG_others Read more about ESH 2026: Nocturnal HBPM and ABPM Show Limited Interchangeability in High-Risk Pregnancy
ESH 2026: Ambulatory SBP Elevation Increased Risk of Cerebral Small Vessel Disease Tags Hypertension RCVD_others Read more about ESH 2026: Ambulatory SBP Elevation Increased Risk of Cerebral Small Vessel Disease
Poor Glycemic Control Corresponded With Vascular Dysfunction in T2DM Tags Hyperglycemia hyperosmolar state hBA1c Read more about Poor Glycemic Control Corresponded With Vascular Dysfunction in T2DM
Fructosamine Reflected Glycemic Variability After GDM Tags ORAL GTT hBA1c Continuous glucose monitoring (CGM) Read more about Fructosamine Reflected Glycemic Variability After GDM
ADA 2026: Semaglutide Improved Glycemic Control in Advanced CKD Tags Diabetic Nephropathy CKD hBA1c GLP-1 agonists Read more about ADA 2026: Semaglutide Improved Glycemic Control in Advanced CKD
ADA 2026: Oral Ribupatide Achieved Up to 11.9% Weight Loss at 26 Weeks Tags GLP-1 agonists Read more about ADA 2026: Oral Ribupatide Achieved Up to 11.9% Weight Loss at 26 Weeks
ADA 2026: Lower Neuroglobin Levels Identified in DSPN Tags Diabetic Neuropathy Read more about ADA 2026: Lower Neuroglobin Levels Identified in DSPN